logo

ZIMV(Delisted)

ZimVie·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 2
Bearish signal 0
Revenue Beats Expectation
EPS Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About ZIMV

Zimvie Inc.

A leading global life sciences company in the dental and spinal markets

--
07/30/2021
02/16/2022
NASDAQ Stock Exchange
1,770
12-31
Common stock
4555 Riverside Drive , Palm Beach Gardens, FL 33410
--
ZimVie Inc., was incorporated as a Delaware corporation on July 30, 2021. The company is a leading medical technology company dedicated to improving the quality of life for spinal and dental patients worldwide. The company develops, manufactures and markets a comprehensive portfolio of products and solutions designed to treat a variety of spinal conditions and support dental replacement and restoration procedures. The company's broad product portfolio covers all areas of the spine, has a market leading position in cervical disc replacement, and is well positioned in the growing global dental implants and biomaterials market, and has a market leading position in oral reconstruction.

Earnings Call

Company Financials

EPS

ZIMV has released its 2025 Q2 earnings. EPS was reported at 0.26, versus the expected 0.23, beating expectations. The chart below visualizes how ZIMV has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

ZIMV has released its 2025 Q2 earnings report, with revenue of 116.66M, reflecting a YoY change of -0.13%, and net profit of -3.95M, showing a YoY change of 1.67%. The Sankey diagram below clearly presents ZIMV's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime

No Data